Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses

J Am Acad Dermatol. 2017 Jul;77(1):177-180. doi: 10.1016/j.jaad.2017.03.020.

Authors

Affiliations

¹ University of California, San Francisco, California. Electronic address: Michaelabrouk1@gmail.com.
² University of California, San Francisco, California.
³ University of New Mexico, Albuquerque, New Mexico.
⁴ University of New Mexico, Albuquerque, New Mexico; University of Colorado Anschutz Medical Center, Aurora, Colorado. Electronic address: Letien62nguyen@gmail.com.

PMID: 28619562
DOI: 10.1016/j.jaad.2017.03.020

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Chronic Disease
Dermatitis, Atopic / drug therapy*
Eczema / drug therapy*
Female
Humans
Male
Middle Aged
Severity of Illness Index
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Thalidomide
apremilast